These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37258203)

  • 1. The lncRNA ADAMTS9-AS1/miR-185-5p/KAT7 ceRNA network inhibits cardiomyocyte hypertrophy in hypertrophic obstructive cardiomyopathy.
    Song B; Li W; Xu X; Dang H; Dong R
    Biomed Res; 2023; 44(3):105-115. PubMed ID: 37258203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA ADAMTS9-AS1/circFN1 Competitively Binds to miR-206 to Elevate the Expression of ACTB, Thus Inducing Hypertrophic Cardiomyopathy.
    Feng W; Han S
    Oxid Med Cell Longev; 2022; 2022():1450610. PubMed ID: 35401927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAMTS9-AS1 Long Non‑coding RNA Sponges miR‑128 and miR-150 to Regulate Ras/MAPK Signaling Pathway in Glioma.
    Javanmard AR; Jahanbakhshi A; Nemati H; Mowla SJ; Soltani BM
    Cell Mol Neurobiol; 2023 Jul; 43(5):2309-2322. PubMed ID: 36449154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS9-AS2 regulates PPP1R12B by adsorbing miR-196b-5p and affects cell cycle-related signaling pathways inhibiting the malignant process of esophageal cancer.
    Chen Z; Tang W; Ye W; Song L; Chen Z
    Cell Cycle; 2022 Aug; 21(16):1710-1725. PubMed ID: 35503407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA WAC antisense RNA 1 mediates hepatitis B virus replication in vitro by reinforcing miR-192-5p/ATG7-induced autophagy.
    Cao M; Yuan D; Jiang H; Zhou G; Chen C; Han G
    Eur J Histochem; 2022 Sep; 66(3):. PubMed ID: 36053263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of IncRNA ZNF667-AS1 in Proliferation and Invasion of Esophageal Squamous Cell Carcinoma Cells via Mediating ceRNA Network.
    Wei L; Gu W; Hu L; Wang K; Huang H; Shen Y
    Crit Rev Eukaryot Gene Expr; 2022; 32(6):57-68. PubMed ID: 35997118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6 Axis.
    Dong B; Zhang F; Zhang W; Gao Y
    Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ADAMTS9-AS1 Restrains the Aggressive Traits of Breast Carcinoma Cells via Sponging miR-513a-5p.
    Fang S; Zhao Y; Hu X
    Cancer Manag Res; 2020; 12():10693-10703. PubMed ID: 33149676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA ADAMTS9-AS1 inhibits the progression of prostate cancer by modulating the miR-142-5p/CCND1 axis.
    Zhou Z; Wu X; Zhou Y; Yan W
    J Gene Med; 2021 May; 23(5):e3331. PubMed ID: 33704879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA ADAMTS9-AS1 inhibits the stemness of lung adenocarcinoma cells by regulating miR-5009-3p/NPNT axis.
    Wang P; Zhang Y; Lv X; Zhou J; Cang S; Song Y
    Genomics; 2023 May; 115(3):110596. PubMed ID: 36870548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p.
    Hou S; Lin Q; Guan F; Lin C
    J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA ADAMTS9-AS1 represses ferroptosis of endometrial stromal cells by regulating the miR-6516-5p/GPX4 axis in endometriosis.
    Wan Y; Gu C; Kong J; Sui J; Zuo L; Song Y; Chen J
    Sci Rep; 2022 Feb; 12(1):2618. PubMed ID: 35173188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of lncRNA MALAT1 Inhibits Angiotensin II-induced Hypertrophic Effects of Cardiomyocytes by Regulating SIRT4 via miR-93-5p.
    Ji H; Qu J; Peng W; Yang L
    Int Heart J; 2022; 63(3):602-611. PubMed ID: 35650160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lnc RNA ZFAS1 regulates the proliferation, apoptosis, inflammatory response and autophagy of fibroblast-like synoviocytes via miR-2682-5p/ADAMTS9 axis in rheumatoid arthritis.
    Yang S; Yin W; Ding Y; Liu F
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NCK1-AS1 promotes non-small cell lung cancer progression via regulating miR-512-5p/p21 axis.
    Luo X; Zhou J; Quan L; Liang Y; Huang P; Chen F; Liu S
    Pathol Res Pract; 2020 Nov; 216(11):153157. PubMed ID: 32858372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DSCAM-AS1 mediates pro-hypertrophy role of GRK2 in cardiac hypertrophy aggravation via absorbing miR-188-5p.
    Chen H; Cai K
    In Vitro Cell Dev Biol Anim; 2020 Apr; 56(4):286-295. PubMed ID: 32377998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q
    J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.